PENS

SONiC, the Leading Open Source Network Operating System, Sees Unparalleled Growth With 10 New Members and Expansion into Enterprise Edge

Retrieved on: 
måndag, april 29, 2024

Unprecedented membership growth, coupled with the availability of new deployment case studies, showcases SONiC's powerful impact within the network operating space.

Key Points: 
  • Unprecedented membership growth, coupled with the availability of new deployment case studies, showcases SONiC's powerful impact within the network operating space.
  • Spanning hardware manufacturers and software developers, these member organizations illustrate the broad industry support for SONiC's mission to enhance data center networking through open source solutions.
  • "SONiC's growth showcases its unique position in pioneering open source networking solutions, and fosters broad industry collaboration," said Arpit Joshipura, general manager, Networking, Edge and IoT, the Linux Foundation.
  • These examples underscore SONiC's role in advancing network technology and its capability to support complex, high-demand environments across the globe.

BlackBerry Reports Third Quarter Fiscal Year 2024 Results

Retrieved on: 
onsdag, december 20, 2023

WATERLOO, ON, Dec. 20, 2023 /PRNewswire/ -- BlackBerry Limited (NYSE: BB; TSX: BB) today reported financial results for the three months ended November 30, 2023 (all figures in U.S. dollars and U.S. GAAP, except where otherwise indicated).

Key Points: 
  • Non-GAAP basic earnings per share of $0.01 and GAAP basic loss per share of $0.04.
  • WATERLOO, ON, Dec. 20, 2023 /PRNewswire/ -- BlackBerry Limited (NYSE: BB; TSX: BB) today reported financial results for the three months ended November 30, 2023 (all figures in U.S. dollars and U.S. GAAP, except where otherwise indicated).
  • "This was a good quarter for BlackBerry.
  • We showed particular strength in Automotive, especially in ADAS where we continue to expand our market position," said John J. Giamatteo, CEO, BlackBerry.

United States Department of Homeland Security Awards New PENS Contract to BlackBerry

Retrieved on: 
onsdag, oktober 11, 2023

WASHINGTON, Oct. 11, 2023 /PRNewswire/ -- BlackBerry Limited (NYSE: BB; TSX: BB) announced today that the United States Department of Homeland Security (DHS) has awarded BlackBerry® a new seven-year Indefinite Delivery, Indefinite Quantity (IDIQ) contract for the creation and sustainment of its new Super Enterprise for Personnel Emergency Notification System (PENS). BlackBerry, American Systems and 4 Points Technology will partner to deliver on the software and services contract, which is for DHS and all its components.

Key Points: 
  • WASHINGTON, Oct. 11, 2023 /PRNewswire/ -- BlackBerry Limited (NYSE: BB; TSX: BB) announced today that the United States Department of Homeland Security (DHS) has awarded BlackBerry® a new seven-year Indefinite Delivery, Indefinite Quantity (IDIQ) contract for the creation and sustainment of its new Super Enterprise for Personnel Emergency Notification System (PENS).
  • The DHS will use BlackBerry® AtHoc® as a department-wide communication and visibility PENS solution for all its employees and contractors.
  • "BlackBerry has been a proud partner of the United States Federal Government for almost thirty years.
  • We are honored to expand our contribution to the nation with BlackBerry AtHoc for the Department of Homeland Security and all its components," said John Chen, Executive Chairman & CEO, BlackBerry.

Independent Sector-Commissioned Research Finds Significant Decrease in Nonprofit Advocacy

Retrieved on: 
tisdag, juli 18, 2023

Washington, July 18, 2023 (GLOBE NEWSWIRE) -- Independent Sector (IS) released today the results of a nationally representative survey of nonprofit institutions that finds a significant decrease in nonprofit engagement in advocacy and lobbying over the last 20 years.

Key Points: 
  • Washington, July 18, 2023 (GLOBE NEWSWIRE) -- Independent Sector (IS) released today the results of a nationally representative survey of nonprofit institutions that finds a significant decrease in nonprofit engagement in advocacy and lobbying over the last 20 years.
  • The research report, “ The Retreat of Influence: Exploring the Decline of Nonprofit Advocacy and Public Engagement ,” fills a 20-year gap in national data on nonprofits’ participation in public policy.
  • In addition to exploring the significant decrease in nonprofit advocacy over the past two decades, “The Retreat of Influence” examines how nonprofit advocacy and lobbying interact with other forms of nonpartisan civic engagement.
  • Read “The Retreat of Influence: Exploring the Decline of Nonprofit Advocacy and Public Engagement” at https://independentsector.co/AdvocacyResearch .

FDA Clears DyAnsys Neurostimulation Device Primary Relief to Treat Post-Cardiac Surgery Pain

Retrieved on: 
torsdag, september 22, 2022

PALO ALTO, Calif., Sept. 22, 2022 /PRNewswire/ -- DyAnsys, Inc., has announced that Primary Relief, a percutaneous electrical neurostimulation device, has been approved to treat pain following a cardiac surgery.

Key Points: 
  • PALO ALTO, Calif., Sept. 22, 2022 /PRNewswire/ -- DyAnsys, Inc., has announced that Primary Relief, a percutaneous electrical neurostimulation device, has been approved to treat pain following a cardiac surgery.
  • Primary Relief offers safe and viable post-operative pain relief that reduces or eliminates the need for narcotics.
  • "This ground-breaking device allows for significant pain relief without the use of narcotics," said DyAnsys Chief Executive Srini Nageshwar.
  • First Relief, Primary Relief and Drug Relief are registered trademarks, of DyAnsys, Inc.
    View original content to download multimedia: https://www.prnewswire.com/news-releases/fda-clears-dyansys-neurostimula...

FDA Clears DyAnsys Neurostimulation Device Primary Relief to Treat C-Section Pain

Retrieved on: 
torsdag, juli 28, 2022

PALO ALTO, Calif., July 28, 2022 /PRNewswire/ -- DyAnsys, Inc., has announced that Primary Relief, a percutaneous electrical neurostimulation device, has been clearedto treat pain following a Caesarean-section (C-section).

Key Points: 
  • PALO ALTO, Calif., July 28, 2022 /PRNewswire/ -- DyAnsys, Inc., has announced that Primary Relief, a percutaneous electrical neurostimulation device, has been clearedto treat pain following a Caesarean-section (C-section).
  • Primary Relief, a PENS device, is a significant alternative to opioids for the treatment of pain following a C-section.
  • DyAnsys offers two companion PENS devices - First Relief, with FDA clearance for the treatment of diabetic neuropathic pain, and Drug Relief, with FDA clearance as an aid to drug withdrawal.
  • First Relief, Primary Relief and Drug Relief are registered trademarks, of DyAnsys, Inc.
    View original content to download multimedia: https://www.prnewswire.com/news-releases/fda-clears-dyansys-neurostimula...

FDA Clears DyAnsys Neurostimulation Device First Relief to treat Diabetic Neuropathic Pain

Retrieved on: 
torsdag, juli 14, 2022

With the FDA clearance of First Relief, this device can be used to treat pain related to diabetic neuropathy.

Key Points: 
  • With the FDA clearance of First Relief, this device can be used to treat pain related to diabetic neuropathy.
  • The wearable device placed on the ear administers continuous pulses of a low-level electrical current over several days.
  • "We are excited to have the FDA clearance of First Relief so that this device, which has been proven effective, can now be used to treat patients who have been experiencing pain related to diabetic neuropathy, said DyAnsys CEO Srini Nageshwar.
  • First Relief, Primary Relief and Drug Relief are registered trademarks, of DyAnsys, Inc.
    View original content to download multimedia: https://www.prnewswire.com/news-releases/fda-clears-dyansys-neurostimula...